Ishares Biotechnology Etf Market Value
| IBB Etf | USD 129.73 2.01 1.53% |
| Symbol | IShares |
The market value of iShares Biotechnology ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is IShares Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Biotechnology's market value can be influenced by many factors that don't directly affect IShares Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IShares Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IShares Biotechnology's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IShares Biotechnology.
| 04/22/2025 |
| 07/21/2025 |
If you would invest 0.00 in IShares Biotechnology on April 22, 2025 and sell it all today you would earn a total of 0.00 from holding iShares Biotechnology ETF or generate 0.0% return on investment in IShares Biotechnology over 90 days. IShares Biotechnology is related to or competes with First Trust, Horizon Kinetics, Harbor Health, Fidelity MSCI, Virtus LifeSci, VanEck Biotech, and Virtus LifeSci. The fund generally will invest at least 80 percent of its assets in the component securities of its index and in investm... More
IShares Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IShares Biotechnology's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iShares Biotechnology ETF upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.76 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 7.57 | |||
| Value At Risk | (2.15) | |||
| Potential Upside | 1.98 |
IShares Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IShares Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IShares Biotechnology's standard deviation. In reality, there are many statistical measures that can use IShares Biotechnology historical prices to predict the future IShares Biotechnology's volatility.| Risk Adjusted Performance | 0.0828 | |||
| Jensen Alpha | 0.1273 | |||
| Total Risk Alpha | (0.1) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (3.17) |
iShares Biotechnology ETF Backtested Returns
At this point, IShares Biotechnology is very steady. iShares Biotechnology ETF holds Efficiency (Sharpe) Ratio of 0.0843, which attests that the entity had a 0.0843 % return per unit of risk over the last 3 months. We have found thirty technical indicators for iShares Biotechnology ETF, which you can use to evaluate the volatility of the entity. Please check out IShares Biotechnology's Risk Adjusted Performance of 0.0828, downside deviation of 1.76, and Market Risk Adjusted Performance of (3.16) to validate if the risk estimate we provide is consistent with the expected return of 0.13%. The etf retains a Market Volatility (i.e., Beta) of -0.0385, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning IShares Biotechnology are expected to decrease at a much lower rate. During the bear market, IShares Biotechnology is likely to outperform the market.
Auto-correlation | 0.04 |
Virtually no predictability
iShares Biotechnology ETF has virtually no predictability. Overlapping area represents the amount of predictability between IShares Biotechnology time series from 22nd of April 2025 to 6th of June 2025 and 6th of June 2025 to 21st of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iShares Biotechnology ETF price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current IShares Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.04 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 4.88 |
iShares Biotechnology ETF lagged returns against current returns
Autocorrelation, which is IShares Biotechnology etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting IShares Biotechnology's etf expected returns. We can calculate the autocorrelation of IShares Biotechnology returns to help us make a trade decision. For example, suppose you find that IShares Biotechnology has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
IShares Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If IShares Biotechnology etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if IShares Biotechnology etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in IShares Biotechnology etf over time.
Current vs Lagged Prices |
| Timeline |
IShares Biotechnology Lagged Returns
When evaluating IShares Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of IShares Biotechnology etf have on its future price. IShares Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, IShares Biotechnology autocorrelation shows the relationship between IShares Biotechnology etf current value and its past values and can show if there is a momentum factor associated with investing in iShares Biotechnology ETF.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iShares Biotechnology ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Biotechnology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Biotechnology Etf:Check out IShares Biotechnology Correlation, IShares Biotechnology Volatility and IShares Biotechnology Alpha and Beta module to complement your research on IShares Biotechnology. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
IShares Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.